Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | GABRP | O00591 | 1/20 | 0.33 |
| ▸ | GABRD | O14764 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.33 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.33 |
| ▸ | GABRE | P78334 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12491887 | 0.88 | POLB (0.42) | POLBTDP1APEX1CTDSP1EGLN1 | |
| SCHEMBL12492014 | 0.88 | POLB (0.42) | POLBTDP1APEX1CTDSP1EGLN1 | |
| SCHEMBL12492015 | 0.88 | POLB (0.42) | POLBTDP1APEX1CTDSP1EGLN1 | |
| SCHEMBL13040844 | 0.84 | POLB (0.37) | POLBTDP1APEX1CTDSP1 | |
| SCHEMBL30782576 | 0.84 | ABAT (0.38) | POLBTDP1APEX1TSHRPMP22 | |
| SCHEMBL20247384 | 0.84 | POLB (0.36) | POLBTDP1APEX1 | |
| SCHEMBL14747711 | 0.84 | POLB (0.37) | POLBTDP1APEX1CTDSP1 | |
| SCHEMBL29276850 | 0.84 | ABAT (0.38) | POLBTDP1APEX1TSHRPMP22 | |
| SCHEMBL13677572 | 0.84 | POLB (0.37) | POLBTDP1APEX1CTDSP1 | |
| SCHEMBL18025413 | 0.84 | POLB (0.37) | POLBTDP1APEX1CTDSP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 595 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4619244-A1 | COMPOSITION FOR PRODUCING A POLYMER, USE OF THE COMPOSITION FOR PRODUCING A POLYMER, AND POLYMER | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2025-09-24 | — | — | EP | claimed |
| WO-2024104982-A1 | COMPOSITION FOR PRODUCING A POLYMER, USE OF THE COMPOSITION FOR PRODUCING A POLYMER, AND POLYMER | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2024-05-23 | — | — | WO | claimed |
| CN-113651955-A | Semi-aromatic polyamide resin with good processability and preparation method and application thereof | 中仑塑业（福建）有限公司 | 2021-11-16 | — | — | CN | claimed |
| US-9957218-B2 | Isomerization of muconic acid | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2018-05-01 | — | — | US | claimed |
| US-20170129839-A1 | ISOMERIZATION OF MUCONIC ACID | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2017-05-11 | — | — | US | claimed |
| EP-3099726-A1 | WATER-REDUCIBLE COATING COMPOSITION | Valspar Sourcing, Inc. (US) | 2016-12-07 | — | — | EP | claimed |
| US-20160326397-A1 | Water-Reducible Coating Composition | VALSPAR SOURCING, INC. (US) | 2016-11-10 | — | — | US | claimed |
| CN-105566511-A | Charge reversal Pulullan derivative and synthesis method and application thereof | UNIV TIANJIN MEDICAL | 2016-05-11 | — | — | CN | claimed |
| CN-102971388-B | Stain-resistant coating composition having excellent durability | KANSAI PAINT CO.,LTD. (JP) | 2016-01-06 | — | — | CN | claimed |
| WO-2015112500-A1 | WATER-REDUCIBLE COATING COMPOSITION | VALSPAR SOURCING, INC. (US) | 2015-07-30 | — | — | WO | claimed |
| US-20050048285-A1 | Oxygen scavenger compositions derived from isophthalic acid and/or terephthalic acid monomer or derivatives thereof | CRYOVAC, INC. | 2005-03-03 | — | — | US | claimed |
| US-6852807-B2 | Resin compositions having biodegradation and hydrolysis properties | HYO SIG JUNG (KR) | 2005-02-08 | — | — | US | claimed |
| EP-1060207-B1 | POLYMERIZATION CATALYSTS FOR POLYESTERS | ALLIED SIGNAL INC (US) | 2004-08-11 | — | — | EP | claimed |
| US-20040039135-A1 | Resin compositions having biodegradation and hydrolysis properties | DAY & DAY CO., LTD. (KP) | 2004-02-26 | — | — | US | claimed |
| EP-1307510-A1 | RESIN COMPOSITIONS HAVING BIODEGRADATION AND HYDROLYSIS PROPERTIES | Jung, Hyo Sig (KR) | 2003-05-07 | — | — | EP | claimed |
| US-6521679-B1 | Polyester aqueous dispersion and method for preparation thereof | MITSUI CHEMICALS, INC. (JP) | 2003-02-18 | — | — | US | claimed |
| WO-2002014431-A1 | RESIN COMPOSITIONS HAVING BIODEGRADATION AND HYDROLYSIS PROPERTIES | JUNG, HYO, SIG (KR) | 2002-02-21 | — | — | WO | claimed |
| EP-1060207-A1 | POLYMERIZATION CATALYSTS FOR POLYESTERS | AlliedSignal Inc. (US) | 2000-12-20 | — | — | EP | claimed |
| US-6034202-A | MIXING ACID CHLORIDE OR ACID BROMIDE SALT AND METAL ALKOXIDE | ALLIEDSIGNAL INC. (US) | 2000-03-07 | — | — | US | claimed |
| WO-1999045056-A1 | POLYMERIZATION CATALYSTS FOR POLYESTERS | ALLIEDSIGNAL INC. (US) | 1999-09-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170129839-A1 | ISOMERIZATION OF MUCONIC ACID | MUC1, CA6, CA13 | POLB 1900/4885TDP1 4639/4885APEX1 2820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.